Gastric Cancer
Copyright ©2005 Baishideng Publishing Group Inc.
World J Gastroenterol. Feb 7, 2005; 11(5): 623-628
Published online Feb 7, 2005. doi: 10.3748/wjg.v11.i5.623
Table 2 Relationship between ERK1/2 expression and clinicopathological characteristics in poorly differentiated gastric cancers (mean±SD).
ItemsnERK1
ERK2
T:N ratio1F (t)PT:N ratio1F (t)P
TNM stage
I, II111.01±0.332.5050.0221.24±0.402.2970.03
III, IV222.64±3.012.05±1.54
Lymph node involvement
+242.49±2.912.4210.0231.98±1.492.1910.036
-91.03±0.361.24±0.44
Serosa invasion
+262.39±2.822.4280.0221.95±1.442.5850.015
-71.01±0.351.14±0.36
Tumor size
<5 cm191.97±2.300.3230.7491.72±1.310.3090.76
>5 cm142.27±2.961.86±1.39
Borrmann classification
I51.27±0.531.420.2570.96±0.221.1690.338
II222.17±1.642.96±3.27
III121.30±0.681.02±0.37
IV31.38±0.191.59±0.20